This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ARCA biopharma Inc (ABIO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 16.76M 2.92M 5.94M 7.02M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 169.00K 125.00K 269.00K 137.00K
Total Current Assets 16.92M 3.04M 6.21M 7.16M
Property, Plant & Equipment, Gross 514.00K 533.00K 533.00K 1.67M
Accumulated Depreciation & Depletion 485.00K 510.00K 467.00K 976.00K
Property, Plant & Equipment, Net 29.00K 23.00K 66.00K 690.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 130.00K 144.00K 224.00K 304.00K
Total Non-Current Assets 159.00K 167.00K 290.00K 994.00K
Liabilities & Shareholder Equity
Total Assets 17.08M 3.21M 6.50M 8.16M
Accounts Payable 597.00K 65.00K 260.00K 388.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 1.50M 305.00K 754.00K 1.19M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 1.00K 0.00 16.00K 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 195.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.00K 0.00 16.00K 195.00K
Total Liabilities 1.50M 305.00K 770.00K 1.38M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 15.58M 2.91M 5.73M 6.77M
Common Par 16.00K 3.00K 12.00K 9.00K
Additional Paid In Capital 90.50M 70.90M 69.39M 65.07M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -74.93M -67.99M -63.67M -58.31M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 15.58M 2.91M 5.73M 6.77M
Total Equity 15.58M 2.91M 5.73M 6.77M
Total Liabilities & Stock Equity 17.08M 3.21M 6.50M 8.16M
Total Common Shares Outstanding 15.69M 2.66M 2.03M 1.47M
Preferred Shares 24.90K 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 8.63M 2.22M 1.67M 1.42M
Diluted Weighted Shares Outstanding 8.63M 2.22M 1.67M 1.42M
Number of Employees 14 6 11 21
Number of Part-Time Employees 0 5 3 1
ABIO News

ABIO ARCA biopharma Inc

Analysts Ratings for ABIO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ABIO ANALYST REPORT

Brokerage Partners

ABIO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs